Advertisement

Prostate Cancer Urology

MRI-Assisted Dose Painting for Improved Prostate Brachytherapy Outcomes

Mar 21, 2025

The following is a summary of “Improving prostate brachytherapy outcomes through MRI-Assisted dominant lesion dose painting,” published in the March 2025 issue of BMC Urology by Rahmani et al.  ...

Prostate-Specific Antigen Density Threshold for Optimizing Biopsy Decisions

Mar 12, 2025

The following is a summary of “Optimal PSA density threshold for prostate biopsy in benign prostatic obstruction patients with elevated PSA levels but negative MRI findings,” published in the Marc...

PSA Reduction and mpMRI to Avoid Biopsy After Focal Therapy

Feb 28, 2025

The following is a summary of “Combining Percentage Prostate-Specific Antigen Reduction and Multiparametric Magnetic Resonance Imaging to Reduce Unnecessary Biopsy After Focal Therapy With High-Inte...

3D CNN-Based AI System for High-Grade PCa Diagnosis Using Novel MRI Sequences

Feb 26, 2025

The following is a summary of “Computer-aided diagnosis based on 3D deep convolutional neural network system using novel 3D magnetic resonance imaging sequences for high-grade prostate cancer,” pu...

Prostate Smooth Muscle Contraction in Laser-Enucleated and TURP Tissues

Feb 25, 2025

The following is a summary of “Smooth muscle contractility of laser-enucleated prostate tissues and impacts of preoperative α1-blocker treatment in patients with and without catheterization,” pub...

Prostate-Specific Antigen Monitoring in Men Using 5-Alpha Reductase Inhibitors

Feb 25, 2025

The following is a summary of “Monitoring of prostate-specific antigen in men with benign prostate enlargement receiving 5-alpha reductase inhibitors: a non-interventional, cross-sectional study of ...

Intraprostatic MRI-Guided Multidrug Microdevice for Assessing Tumor Response in Prostate Cancer

Feb 20, 2025

The following is a summary of “Novel Intraprostatic Magnetic Resonance–Guided Implantation of Multidrug-Eluting Microdevice for Testing of Systemic Therapy Agents In Situ: Proof of Concept in Inte...

Diagnostic Value of M-Emax in Prostate Diseases Using T-SWE

Feb 19, 2025

The following is a summary of “Application of mean maximum Young’s modulus value as a new parameter for differential diagnosis of prostate diseases,” published in the January 2025 issue of Scien...

Role of INO80B in Reducing Prostate Cell Overgrowth

Feb 03, 2025

The following is a summary of “A cross-tissue transcriptome-wide association study identifies new susceptibility genes for benign prostatic hyperplasia,” published in the January 2025 issue of Sci...

Postoperative Satisfaction Changes Following Robot-Assisted Prostatectomy

Jan 29, 2025

The following is a summary of “Longitudinal changes in factors affecting postoperative patient satisfaction after robot-assisted radical prostatectomy: an assessment using a patient-reported questio...

Prognostic Value of IDC-P Subtypes and PORT in Localized PCa

Jan 23, 2025

The following is a summary of “Prognostic value of intraductal carcinoma subtypes and postoperative radiotherapy for localized prostate cancer,” published in the January 2025 issue of Urology by C...

Impact of Mobile Internet Management on Postoperative Care for Prostate Cancer

Jan 10, 2025

The following is a summary of “Application of mobile internet management in the continuing care of patients after radical prostatectomy,” published in the December 2024 issue of Urology by Peng et...

Bone Health Management in Endocrine-Treated Patients With Prostate Cancer

Dec 30, 2024

The following is a summary of “Bone health management in endocrine-treated patients with prostate cancer: a summary of evidence,” published in the December 2024 issue of Urology by Chen et al.  ...

Role of AR Alterations in ctDNA Detection for mCRPC

Dec 24, 2024

The following is a summary of “AR alterations inform circulating tumor DNA detection in metastatic castration resistant prostate cancer patients,” published in the December 2024 issue of Urology b...

Medium-Term Outcomes of HIFU and RP in PC

Dec 18, 2024

The following is a summary of “Whole-gland or Subtotal High-intensity Focused Ultrasound Versus Radical Prostatectomy: The Prospective, Noninferiority, Nonrandomized HIFI Trial,” published in the ...

Impact of 11-Ketotestosterone on Progression in Patients With CRPC

Nov 28, 2024

The following is a summary of “High 11-ketotestosterone linked to shorter time to castration resistance in recurrent non-metastatic prostate cancer,” published in the November 2024 issue of Urolog...

Holmium Laser Enucleation vs PVP for Benign Prostatic Hyperplasia

Nov 18, 2024

The following is a summary of “A meta-analysis comparing treatment of benign prostatic hyperplasia with holmium laser enucleation and photoselective greenlight vaporization,” published in the Apri...

Radiomics and Clinical Features in Predicting B-TUEP Effectiveness

Nov 18, 2024

The following is a summary of “Clinical-radiomics combination model for predicting the short-term efficacy of bipolar transurethral enucleation of the prostate in patients with benign prostatic hype...

MRI-Based Radiomics Significantly Outperform PI-RADS v2.1 for PCa Diagnosis With PSA 4–10 ng/mL

Oct 25, 2024

The following is a summary of “Comparison in prostate cancer diagnosis with PSA 4–10 ng/mL: radiomics-based model VS. PI-RADS v2.1,” published in the October 2024 issue of Urology by Li et al. ...

Lutetium-177 Treatment Effective in Both mCRCP & mHSPC

Oct 18, 2024

In recent years, 177Lu-PSMA treatment of prostate cancer has become a major field of investigation. Results from the SPLASH and UpFrontPSMA trials, showed an improved efficacy with 177Lu-PSMA over sta...

SUBSPECIALTIES

Advertisement